S&P 500   3,404.78 (+0.11%)
DOW   27,614.41 (-0.26%)
QQQ   282.15 (+0.60%)
AAPL   116.76 (+1.49%)
MSFT   213.00 (+1.39%)
FB   282.07 (+1.79%)
GOOGL   1,586.72 (+0.15%)
AMZN   3,266.77 (+1.86%)
TSLA   423.35 (+0.73%)
NVDA   531.14 (+1.04%)
BABA   317.66 (+3.52%)
CGC   18.73 (+1.08%)
GE   7.12 (-3.52%)
MU   51.63 (-0.98%)
AMD   77.97 (-5.18%)
T   27.05 (-1.21%)
F   7.94 (-1.12%)
ACB   4.15 (-5.68%)
GILD   59.59 (-0.62%)
NFLX   485.89 (-0.48%)
NIO   27.60 (+6.11%)
BA   157.05 (-2.35%)
DIS   123.80 (-0.21%)
S&P 500   3,404.78 (+0.11%)
DOW   27,614.41 (-0.26%)
QQQ   282.15 (+0.60%)
AAPL   116.76 (+1.49%)
MSFT   213.00 (+1.39%)
FB   282.07 (+1.79%)
GOOGL   1,586.72 (+0.15%)
AMZN   3,266.77 (+1.86%)
TSLA   423.35 (+0.73%)
NVDA   531.14 (+1.04%)
BABA   317.66 (+3.52%)
CGC   18.73 (+1.08%)
GE   7.12 (-3.52%)
MU   51.63 (-0.98%)
AMD   77.97 (-5.18%)
T   27.05 (-1.21%)
F   7.94 (-1.12%)
ACB   4.15 (-5.68%)
GILD   59.59 (-0.62%)
NFLX   485.89 (-0.48%)
NIO   27.60 (+6.11%)
BA   157.05 (-2.35%)
DIS   123.80 (-0.21%)
S&P 500   3,404.78 (+0.11%)
DOW   27,614.41 (-0.26%)
QQQ   282.15 (+0.60%)
AAPL   116.76 (+1.49%)
MSFT   213.00 (+1.39%)
FB   282.07 (+1.79%)
GOOGL   1,586.72 (+0.15%)
AMZN   3,266.77 (+1.86%)
TSLA   423.35 (+0.73%)
NVDA   531.14 (+1.04%)
BABA   317.66 (+3.52%)
CGC   18.73 (+1.08%)
GE   7.12 (-3.52%)
MU   51.63 (-0.98%)
AMD   77.97 (-5.18%)
T   27.05 (-1.21%)
F   7.94 (-1.12%)
ACB   4.15 (-5.68%)
GILD   59.59 (-0.62%)
NFLX   485.89 (-0.48%)
NIO   27.60 (+6.11%)
BA   157.05 (-2.35%)
DIS   123.80 (-0.21%)
S&P 500   3,404.78 (+0.11%)
DOW   27,614.41 (-0.26%)
QQQ   282.15 (+0.60%)
AAPL   116.76 (+1.49%)
MSFT   213.00 (+1.39%)
FB   282.07 (+1.79%)
GOOGL   1,586.72 (+0.15%)
AMZN   3,266.77 (+1.86%)
TSLA   423.35 (+0.73%)
NVDA   531.14 (+1.04%)
BABA   317.66 (+3.52%)
CGC   18.73 (+1.08%)
GE   7.12 (-3.52%)
MU   51.63 (-0.98%)
AMD   77.97 (-5.18%)
T   27.05 (-1.21%)
F   7.94 (-1.12%)
ACB   4.15 (-5.68%)
GILD   59.59 (-0.62%)
NFLX   485.89 (-0.48%)
NIO   27.60 (+6.11%)
BA   157.05 (-2.35%)
DIS   123.80 (-0.21%)
Log in
NASDAQ:RPRX

Royalty Pharma Price Target, Predictions & Analyst Ratings

$37.95
-0.82 (-2.12 %)
(As of 10/27/2020 01:14 PM ET)
Add
Compare
Today's Range
$37.68
Now: $37.95
$38.98
50-Day Range
$38.56
MA: $41.29
$44.81
52-Week Range
$38.10
Now: $37.95
$56.50
Volume17,517 shs
Average Volume1.57 million shs
Market Capitalization$13.89 billion
P/E RatioN/A
Dividend Yield1.54%
BetaN/A

Analyst Ratings

Royalty Pharma (NASDAQ:RPRX) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
10 Wall Street analysts have issued ratings and price targets for Royalty Pharma in the last 12 months. Their average twelve-month price target is $52.33, predicting that the stock has a possible upside of 37.90%. The high price target for RPRX is $56.00 and the low price target for RPRX is $47.00. There are currently 6 hold ratings and 4 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
RPRX Consensus Rating: HoldHoldHoldN/A
RPRX Consensus Rating Score: 2.402.402.40N/A
RPRX Analyst Ratings: 0 Sell Rating(s)
6 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
RPRX Consensus Price Target: $52.33$52.33$52.33N/A
RPRX Price Target Upside: 37.90% upside9.85% upside9.85% upsideN/A

Royalty Pharma (NASDAQ:RPRX) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Royalty Pharma (NASDAQ:RPRX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/14/2020Evercore ISIInitiated CoverageHoldHigh
7/13/2020Bank of AmericaInitiated CoverageBuy$55.00High
7/13/2020CitigroupInitiated CoverageNeutral$50.00High
7/13/2020Morgan StanleyInitiated CoverageEqual Weight$51.00High
7/13/2020SunTrust BanksInitiated CoverageBuy$56.00High
7/13/2020UBS GroupInitiated CoverageNeutral$52.00High
7/13/2020JPMorgan Chase & Co.Initiated CoverageNeutral$50.00High
7/13/2020CowenInitiated CoverageOutperform$55.00High
7/13/2020BofA SecuritiesInitiated CoverageBuy$55.00High
7/12/2020Goldman Sachs GroupInitiated CoverageNeutral$47.00High
(Data available from 10/27/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 10/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.